Pipeline
Orphan diseases
GNR-055
MPS II, Hunter syndrome (INN: verenafusp alfa)
GNR-071
Maroteaux-Lamy syndrome, Mucopolysaccharidosis type VI (INN: galsulfase)
GNR-097
Duchenne muscular dystrophy (INN: gene therapy)
Autoimmune diseases
GNR-086
Systemic juvenile idiopathic arthritis (INN: canakinumab)
GNR-093
Multiple sclerosis (INN: natalizumab)
GNR-085
Multiple sclerosis (INN: ocrelizumab)
Oncology
GNR-107
Metastatic colorectal cancer (INN: panitumumab)
Ophtalmology
GNR-098
Age-related macular degeneration, diabetic retinopathy (INN: aflibercept)
Allergology
GNR-127
Allergen immunotherapy